Literature DB >> 8813965

Malignant lymphoma in congenital dyserythropoietic anaemia type III.

W G McCluggage1, D Hull, E Mayne, H Bharucha, S N Wickramasinghe.   

Abstract

A 60 year old woman with congenital dyserythropoietic anaemia (CDA) type III developed a malignant T cell lymphoma with cutaneous and widespread nodal involvement. Bone marrow aspirates showed erythroid hyperplasia and dyserythropoiesis with multinucleate erythroblasts and gigantoblasts, in keeping with CDA type III. Electron microscopy showed multinucleate erythroblasts with notably irregular nuclear outlines and intranuclear clefts. The development of malignant lymphoma in this patient, together with a documented high prevalence of monoclonal gammopathy and multiple myeloma and a single case of Hodgkin's disease, may indicate an increased incidence of lymphoproliferative disease in CDA type III.

Entities:  

Mesh:

Year:  1996        PMID: 8813965      PMCID: PMC500581          DOI: 10.1136/jcp.49.7.599

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Hereditary benign erythroreticulosis.

Authors:  I BERGSTROM; L JACOBSSON
Journal:  Blood       Date:  1962-03       Impact factor: 22.113

2.  Familial erythroid multinuclearity.

Authors:  J A WOLFF; F H VON HOFE
Journal:  Blood       Date:  1951-12       Impact factor: 22.113

3.  Congenital dyserythropoietic anaemia, type 3.

Authors:  R Goudsmit; D Beckers; J I De Bruijne; C P Engelfriet; J James; A F Morselt; E Reynierse
Journal:  Br J Haematol       Date:  1972-07       Impact factor: 6.998

4.  Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts.

Authors:  H Heimpel; F Wendt
Journal:  Helv Med Acta       Date:  1968-03

5.  Observations on two members of the Swedish family with congenital dyserythropoietic anaemia, type III.

Authors:  S N Wickramasinghe; A Wahlin; D Anstee; S F Parsons; G Stopps; I Bergstrom; M Eriksson; H Sandstrom; S Shiels
Journal:  Eur J Haematol       Date:  1993-04       Impact factor: 2.997

6.  Congenital dyserythropoietic anemia in treated Hodgkin's disease.

Authors:  R K Byrnes; R Dhru; A M Brady; W P Galen; B Hopper
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

7.  Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III.

Authors:  H Sandström; A Wahlin; M Eriksson; I Bergström; S N Wickramasinghe
Journal:  Eur J Haematol       Date:  1994-01       Impact factor: 2.997

8.  Congenital dyserythropoietic anaemias: splenectomy as a mode of therapy.

Authors:  V P Choudhry; A K Saraya; J Kasturi; P K Rath
Journal:  Acta Haematol       Date:  1981       Impact factor: 2.195

9.  A new case of congenital dyserythropoietic anaemia, type III: studies of the cell cycle distribution and ultrastructure of erythroblasts and of nucleic acid synthesis in marrow cells.

Authors:  S N Wickramasinghe; T E Parry; C Williams; A N Bond; M Hughes; S Crook
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

  9 in total
  2 in total

1.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

2.  Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.

Authors:  Manuel Méndez; María Isabel Moreno-Carralero; Valeria L Peri; Rafael Camacho-Galán; José M Bosch-Benítez; Jorge Huerta-Aragonés; Jorge Sánchez-Calero-Guilarte; María Belén Moreno-Risco; Juan Manuel Alonso-Domínguez; María José Morán-Jiménez
Journal:  Ann Hematol       Date:  2020-11-07       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.